ZBD may benefit from the new standard specification formula granule related business will welcome a major positive development

2021-03-08 15:34:00
  Recently, the State Food and Drug Administration, the State Administration of Traditional Chinese Medicine, the National Health Commission and the National Medical Insurance Administration jointly issued the Announement on Ending the Pilot Work of TCM Granules, which has put on the agenda the formulation of national drug standards for TCM granules, which will help promote the standardized development of the industry of TCM granules. At the same time, with the end of the pilot policy, the Chinese medicine formula granule market will open a new pattern. By virtue of the advantages of medicinal materials resources, production technology and quality control, the business of TCM formula pellets of ZBD Pharmaceutical Company may benefit from this adjustment, and the related business will embrace great favorable development opportunities. 
   According to the interpretation of the State Food and Drug Administration, with the introduction of the first batch of national standards for TCM formula granules, the problems restricting the development of the industry, such as market chaos and uneven product quality, will soon be solved. The competition of the future will be the endorsement of compliance, strong technology and enterprise strength. With the end of the pilot, the market of TCM formula granules is bound to be reshuffle. High-quality TCM formula granules manufacturers, including ZBD Pharmaceutical Co., Ltd., will embrace the blue ocean market of tens of billions of yuan, which has been widely paid continuous and high attention by the capital market. 
 
   It is understood that since its establishment, ZBD Pharmaceutical has been continuously deepening the cultivation of traditional Chinese medicine varieties, practicing the engineering construction concept of "scientific and technological traditional Chinese medicine" and "ecological traditional Chinese medicine", and continuously devoting itself to the research and practice of the modernization of traditional Chinese medicine. Company of traditional Chinese medicine formula particles "life cycle" in quality control model, from product standards, medicine source control, process control, product release control, market circulation of multiple links such as product quality monitoring, implementation of traditional Chinese medicine formula particles from the medicine to patients with the whole process of quality control, total quality management level.
 
   At the source of prescription granule medicinal materials, ZBD Pharmaceutical has established a perfect standard quality control and quality traceability system of Chinese medicinal materials, and built GAP Chinese medicinal materials planting base to ensure that the planting of Chinese medicinal materials can meet the requirements of "high quality, stability and control". The rest of the raw materials of Chinese medicinal materials are authentic medicinal materials with clear origin. The effective content of medicinal materials is detected by spectrogram, and harmful elements such as pesticide residues and heavy metals are detected in depth. The quality of products is better controlled from the source, and the whole process of traceability from Chinese medicinal materials to patients is realized.
 
   In the production process, ZBD Pharmaceutical relies on the intelligent manufacturing system, adopts the full automatic production line and near-infrared online detection technology, and the production process quality control and product release control. Through refining production process quality control indicators, advanced quality control equipment, and creating a risk early warning and prevention system based on big data analysis, the quality management of TCM formula granules has realized the transformation from pre-prevention to process control. At present, we have stable production and supply capacity. It is reported that the cumulative production capacity of ZBD pharmaceutical Chinese medicine formula granules can reach more than 300 million bags/year, which will effectively ensure the timely supply of products to meet the needs of different drugs. 
 
   At present, ZBD Pharmaceutical has successfully filed 550 formula particles of commonly used traditional Chinese medicine and obtained market access. We will actively participate in the research and formulation of national and provincial standards for formula granules to ensure that the formula granules of ZBD Pharmaceutical Co., Ltd have strong competitiveness and market advantage in terms of quality and efficacy. The company has successively cooperated with Zhejiang University, Peking University and other scientific research institutions to carry out formula pellet research, and made a large number of scientific research achievements in the core fields of formula pellet production, quality control, technology exploration and so on, which laid a solid foundation for the production and research of formula pellet.
 
   Layout of traditional Chinese medicines with complete industry chain, as well as in intelligent manufacturing under highly controlled and large production capacity, product quality steady, high speed will be treasured island TCM formula granule keywords of the business development, with China's traditional Chinese medicine formula particles are expanding market demand, treasured island pharmaceutical industry will further expand the brand influence and market share, with traditional Chinese medicine formula particles to build company's new profit growth point, to further improve the company's performance.